Product Description
Since last manyAA years SaintroyAA LifescienceAA is leading manufacture, export andsupplier ofAA Aldesleukin Injection from Surat, Gujarat, India. Aldesleukin Injection using recombinant DNA technology and is marketed as a protein therapeutic and branded as Proleukin.
Tags: Aldesleukin Injection manufacturer, Aldesleukin Injection Exporter, Aldesleukin Injection supplier, and Aldesleukin Injection, whogmp approved AldesleukinAA Injection manufacturer and supplier, Aldesleukin Injection Distributor, Aldesleukin Injection shipper, Aldesleukin Injection 1.3 mg Aldesleukin InjectionAA 1.3 mgAA supplier, Aldesleukin InjectionAA 1.3 mg.
ISO/GMP/cGMP/WHOGMP/NAFDAC approved, PPB Kenya approved/USFDA approved/EUGMP approved/MOH Iran approved manufacturing facility inAA Gujarat, India.
Registration: Saintroy LifescienceAA is interested inregistration of own brand or customer brands in ministryAA of health of clientsAA country and we also provide the products samples, COA, COPP, ACTorAA CTD dossier, DMF, Manufacturing license, Free sales certificate and other required documents.
Export CountryAA :Saintroy Lifescience Aldesleukin InjectionAA AA export to USA, Canada,Germany, Europe, France, Ghana, Nigeria, Kenya, Senegal, Sudan,UAE, Kuwait,Dubai, Cameroon, Lebanon, Peru, Chile, Somalia, Philippines, Myanmar, Maldives,Thailand, Singapore, Malaysia, Hong Kong, China, Zimbabwe, Togo, Burkina Faso,Niger,Guinea Bissau, Congo, Democratic of republic, Ivory Costa, Oman,Guatemala, Nicaragua, Salvador, Qatar, Costa Rica, Panama, Cuba, Colombia,Bolivia, Argentine, Algeria, Guyana, Morocco, Jordan, Bahrain, Iran, Egypt,Kyrgyzstan, Uzbekistan, Kazakhstan.
Advanced Immunotherapy for Cancer TreatmentAldesleukin Injection is primarily used in the management of metastatic renal cell carcinoma and metastatic melanoma. Its mechanism harnesses the body's immune response, helping to target and destroy malignant cells. Marketed by various pharmaceutical manufacturers in India, it aids specialists in delivering precision immunotherapy to eligible patients. Its activity is derived from recombinant human IL-2, ensuring targeted efficacy in complex oncological cases.
Safe and Monitored AdministrationThis injection must be reconstituted with sterile water and administered strictly under the guidance of healthcare professionals. It is suitable for both intravenous infusion and subcutaneous injection. Because of the potential for serious immune-related reactions, close medical supervision and patient monitoring are essential throughout the treatment course. Proper adherence to preparation and administration protocols maximizes safety and therapeutic benefit.
FAQ's of Aldesleukin Injection:
Q: How should Aldesleukin Injection be prepared and administered?
A: Aldesleukin Injection should be reconstituted with sterile water for injection as per manufacturer instructions. It can be given through intravenous infusion or subcutaneous injection, based on your physician's recommendation. Never mix Aldesleukin with other medications in the same infusion line.
Q: What are the indications for using Aldesleukin Injection?
A: Aldesleukin is prescribed for the treatment of adults with metastatic renal cell carcinoma and metastatic melanoma as part of immunotherapy protocols. It is used to stimulate the immune system to recognize and attack certain cancer cells.
Q: When should I store and how long can I use Aldesleukin after reconstitution?
A: Unopened vials should be stored in a cool, dry place as per the label instructions. Each vial has a shelf life of 2 years. After reconstitution, use the solution immediately or as directed by your healthcare provider-never store reconstituted solution for future use unless specified.
Q: What precautions should be observed during Aldesleukin therapy?
A: This injection should only be used under close medical supervision because it can cause severe immune reactions. Frequent monitoring by healthcare professionals is necessary to promptly address any adverse effects or complications.
Q: Where can Aldesleukin Injection be obtained?
A: Aldesleukin Injection is a prescription-only medication. It is available from hospital pharmacies and authorized pharmaceutical distributors, dealers, and wholesalers in India as supplied by various manufacturers.
Q: What benefits does Aldesleukin provide in cancer therapy?
A: Aldesleukin works by activating the body's immune defenses, increasing the ability of certain immune cells to target and destroy cancer cells. This targeted immunotherapy can improve outcomes in selected patients with metastatic melanoma or renal cell carcinoma.